This expert group consensus statement emphasises the need for standardising the definition
of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis …

Interstitial lung diseases (ILDs) are a large and diverse group of rare and chronic respiratory
disorders, with idiopathic pulmonary fibrosis (IPF) being the most common and best-studied …

Within the Interstitial Lung Diseases (ILD), patients with idiopathic pulmonary fibrosis (IPF)
and a subset of those with non-IPF fibrotic ILD have a distinct clinical phenotype of …

Objective: This study aimed to investigate whether deep-learning reconstruction (DLR)
improves interobserver agreement in the evaluation of honeycombing for patients with …

Background Previous work has shown the ability of Fibresolve, a machine learning system,
to non-invasively classify idiopathic pulmonary fibrosis (IPF) with a pre-invasive sensitivity of …

Background Identifying systemic sclerosis (SSc) and idiopathic pulmonary fibrosis (IPF)
patients at risk of more rapid forced vital capacity (FVC) decline could improve trial design …

Currently, several imaging techniques are being used for a comprehensive evaluation of
patients with suspected pulmonary hypertension (PH), in order to provide information that …

High-resolution computed tomography (HRCT) plays a pivotal role in the diagnosis and
management of interstitial lung diseases (ILDs), particularly given the approval of antifibrotic …

Chest HRCT is the gold standard for the recognition of lung alteration patterns underlying
interstitial lung diseases (ILDs) and those entities with potential for fibrotic evolution. In the …

Introduction: Pneumonia is an infection that settles in the lungs, which can affect the
pulmonary alveoli where the terminal branches of the bronchi and interstices flow. They are …